HIF1A and idiopathic pulmonary fibrosis: Studies on mesenchymal stem/stromal cells, also used in IPF therapy [67], have shown that HIF-1α expression not only influences glycolytic activity, but also mitochondrial oxidative phosphorylation under hypoxic conditions [61].